Viva Biotech completes HK$0.59 million buyback on 15 June; cumulative repurchases reach 28.59 million shares

Bulletin Express06-15

Viva Biotech Holdings (incorporated in the Cayman Islands with limited liability) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 15 June 2026, detailing the latest activity under its share repurchase programme.

Key points

1. Latest repurchase – 15 June 2026 • Shares bought: 500,000 ordinary shares • Price range: HK$1.18–HK$1.19 per share • Total consideration: HK$0.59 million • Purpose: cancellation (no treasury shares will be held)

2. Cumulative activity since 8 May 2026 • Total shares repurchased but not yet cancelled: 28.59 million • Represents: 1.34 % of issued shares as at the 12 June 2025 mandate date • Average prices: HK$1.14–HK$1.57 per share across individual trading days

3. Capital structure • Issued shares outstanding (excluding treasury shares) remained unchanged at 2.13 billion as at both 12 June and 15 June 2026. • No treasury shares are recorded on the balance sheet.

4. Repurchase mandate utilisation • Shares authorised under the 12 June 2025 mandate: 212.84 million • Shares repurchased to date under the mandate: 28.59 million • Utilisation of mandate: 13.44 % • Moratorium on new share issues or treasury share transfers applies until 15 July 2026, in accordance with Hong Kong listing rules.

The company confirmed that all repurchases were executed on the Stock Exchange of Hong Kong, fully authorised by the board, and compliant with all applicable listing and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1117333292?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117333292","market":"us","top_or_hot":-1,"title":"Viva Biotech completes HK$0.59 million buyback on 15 June; cumulative repurchases reach 28.59 million shares","media":"Bulletin Express","content":"<p>Viva Biotech Holdings (incorporated in the Cayman Islands with limited liability) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 15 June 2026, detailing the latest activity under its share repurchase programme.</p>\n<p>Key points</p>\n<p>1. Latest repurchase – 15 June 2026  \n• Shares bought: 500,000 ordinary shares  \n• Price range: HK$1.18–HK$1.19 per share  \n• Total consideration: HK$0.59 million  \n• Purpose: cancellation (no treasury shares will be held)</p>\n<p>2. Cumulative activity since 8 May 2026  \n• Total shares repurchased but not yet cancelled: 28.59 million  \n• Represents: 1.34 % of issued shares as at the 12 June 2025 mandate date  \n• Average prices: HK$1.14–HK$1.57 per share across individual trading days</p>\n<p>3. Capital structure  \n• Issued shares outstanding (excluding treasury shares) remained unchanged at 2.13 billion as at both 12 June and 15 June 2026.  \n• No treasury shares are recorded on the balance sheet.</p>\n<p>4. Repurchase mandate utilisation  \n• Shares authorised under the 12 June 2025 mandate: 212.84 million  \n• Shares repurchased to date under the mandate: 28.59 million  \n• Utilisation of mandate: 13.44 %  \n• Moratorium on new share issues or treasury share transfers applies until 15 July 2026, in accordance with Hong Kong listing rules.</p>\n<p>The company confirmed that all repurchases were executed on the Stock Exchange of Hong Kong, fully authorised by the board, and compliant with all applicable listing and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viva Biotech completes HK$0.59 million buyback on 15 June; cumulative repurchases reach 28.59 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViva Biotech completes HK$0.59 million buyback on 15 June; cumulative repurchases reach 28.59 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-15 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viva Biotech Holdings (incorporated in the Cayman Islands with limited liability) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 15 June 2026, detailing the latest activity under its share repurchase programme.</p>\n<p>Key points</p>\n<p>1. Latest repurchase – 15 June 2026  \n• Shares bought: 500,000 ordinary shares  \n• Price range: HK$1.18–HK$1.19 per share  \n• Total consideration: HK$0.59 million  \n• Purpose: cancellation (no treasury shares will be held)</p>\n<p>2. Cumulative activity since 8 May 2026  \n• Total shares repurchased but not yet cancelled: 28.59 million  \n• Represents: 1.34 % of issued shares as at the 12 June 2025 mandate date  \n• Average prices: HK$1.14–HK$1.57 per share across individual trading days</p>\n<p>3. Capital structure  \n• Issued shares outstanding (excluding treasury shares) remained unchanged at 2.13 billion as at both 12 June and 15 June 2026.  \n• No treasury shares are recorded on the balance sheet.</p>\n<p>4. Repurchase mandate utilisation  \n• Shares authorised under the 12 June 2025 mandate: 212.84 million  \n• Shares repurchased to date under the mandate: 28.59 million  \n• Utilisation of mandate: 13.44 %  \n• Moratorium on new share issues or treasury share transfers applies until 15 July 2026, in accordance with Hong Kong listing rules.</p>\n<p>The company confirmed that all repurchases were executed on the Stock Exchange of Hong Kong, fully authorised by the board, and compliant with all applicable listing and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1117333292","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117333292","pubTimestamp":1781517742,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Viva Biotech Holdings (incorporated in the Cayman Islands with limited liability) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 15 June 2026, detailing the latest activity...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01873":"维亚生物"},"translate_title":"维亚生物于6月15日完成59万港元回购；累计回购达2859万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01873":1},"content_text":"Viva Biotech Holdings (incorporated in the Cayman Islands with limited liability) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 15 June 2026, detailing the latest activity under its share repurchase programme.\nKey points\n1. Latest repurchase – 15 June 2026  \n• Shares bought: 500,000 ordinary shares  \n• Price range: HK$1.18–HK$1.19 per share  \n• Total consideration: HK$0.59 million  \n• Purpose: cancellation (no treasury shares will be held)\n2. Cumulative activity since 8 May 2026  \n• Total shares repurchased but not yet cancelled: 28.59 million  \n• Represents: 1.34 % of issued shares as at the 12 June 2025 mandate date  \n• Average prices: HK$1.14–HK$1.57 per share across individual trading days\n3. Capital structure  \n• Issued shares outstanding (excluding treasury shares) remained unchanged at 2.13 billion as at both 12 June and 15 June 2026.  \n• No treasury shares are recorded on the balance sheet.\n4. Repurchase mandate utilisation  \n• Shares authorised under the 12 June 2025 mandate: 212.84 million  \n• Shares repurchased to date under the mandate: 28.59 million  \n• Utilisation of mandate: 13.44 %  \n• Moratorium on new share issues or treasury share transfers applies until 15 July 2026, in accordance with Hong Kong listing rules.\nThe company confirmed that all repurchases were executed on the Stock Exchange of Hong Kong, fully authorised by the board, and compliant with all applicable listing and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1117333292","isCrawlerRequest":true}